Top

Published in:

Open Access 01-11-2020 | Escherichia Coli | Original Article

Neonatal and young infant sepsis by Group B Streptococci and Escherichia coli: a single-center retrospective analysis in Germany—GBS screening implementation gaps and reduction in antibiotic resistance

Authors: Maren Doenhardt, Barbara Seipolt, Lars Mense, Jennifer Lucia Winkler, Alexander Thürmer, Mario Rüdiger, Reinhard Berner, Jakob Armann

Published in: European Journal of Pediatrics | Issue 11/2020

Abstract

The last nationwide surveillance study on neonatal and young infant sepsis due to Group B Streptococci (GBS) and Escherichia coli in Germany was conducted between 2009 and 2010. The aim of this study is to provide longitudinal epidemiological data on neonatal and young infant sepsis caused by GBS and E. coli to reevaluate existing data and to inform clinical decision-making. Every positive blood culture for GBS and E. coli within the first 90 days of life that occurred at our center from 2008 until 2018 was identified. The epidemiological, clinical, laboratory, and microbiological data of all affected patients were analyzed through retrospective chart review, along with the pathogen’s antimicrobial susceptibility results. In total, 106 episodes of neonatal sepsis were described; 31% (n = 33) being caused by GBS and 69% (n = 73) by E. coli; 87% of GBS early-onset disease (EOD) cases did not receive intrapartum antibiotic prophylaxis (IAP). Contrary to general trends, the proportion of resistant E. coli isolates decreased for all tested antibiotics over time. Coincidentally, antenatal antibiotic use beyond IAP during that period decreased significantly in our center.

Conclusions: (1) Data at our center suggests at least a regional implementation gap in GBS screening and IAP. (2) The decline in the resistance rate of E. coli for all antimicrobial substances might indicate that the reduction of prenatal antibiotics use is beneficial and that neonatal antibiotic stewardship programs should include pregnant women as well.

What is Known:

• GBS screening and intrapartum antibiotic prophylaxis led to a 32%-reduction in GBS disease in Germany with a 0.75 (92:122) ratio of early-onset disease to late-onset disease in 2009–2010.

• Prenatal antibiotic use might increase the risk of E. coli early-onset disease and antibiotic resistances.

What is New:

• The GBS early-onset disease rates were twice as high as those of late-onset disease, the ratio was 1.75 (21:12) in 2008–2018 at our institution. This suggests that there are at least regional implementation gaps in the antenatal GBS screening in Germany.

• We found a decline in E. coli resistance rates over time for all antimicrobial substances. Reduction in use of prenatal antibiotics might be an explanation.

Available only for authorised users

Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) –Ständige Kommission Leitlinien (2016) S2k-Leitlinie 024–020 "Prophylaxe der Neugeborenensepsis - frühe Form - durch Streptokokken der Gruppe B".Available at https://www.awmf.org/uploads/tx_szleitlinien/024-020l_S2k_Prophylaxe_Neugeborenensepsis_Streptokokken_2016-04.pdf. Accessed 12 Jun 2019

Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG (2008) Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 121(4):689–696. https://doi.org/10.1542/peds.2007-2171 CrossRefPubMed

Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (ed) (2016) GERMAP 2015. Antibiotika-Resistenz und -Verbauch; Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland, 4th edn. Antiinfectives Intelligence, Rheinbach

Donà D, Barbieri E, Daverio M, Lundin R, Giaquinto C, Zaoutis T, Sharland M (2020) Implementation and impact of pediatric antimicrobial stewardship programs: a systematic scoping review. Antimicrob Resist Infect Control 9:3. https://doi.org/10.1186/s13756-019-0659-3 CrossRefPubMedPubMedCentral

Gastmeier P, Sohr D, Schwab F, Behnke M, Zuschneid I, Brandt C, Dettenkofer M, Chaberny IF, Rüden H, Geffers C (2008) Ten years of KISS: the most important requirements for success. J Hosp Infect 70(SUPPL. 1):11–16. https://doi.org/10.1016/S0195-6701(08)60005-5 CrossRefPubMed

Hamada S, Vearncombe M, McGeer A, Shah PS (2008) Neonatal group B streptococcal disease: incidence, presentation, and mortality. J Matern Fetal Neonatal Med 21(1):53–57. https://doi.org/10.1080/14767050701787474 CrossRefPubMed

Heideking M, Lander F, Hufnagel M, Pfeifer Y, Wicker E, Krause G, Berner R (2013) Antibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009-2010. Eur J Clin Microbiol Infect Dis 32(9):1221–1223. https://doi.org/10.1007/s10096-013-1871-3 CrossRefPubMed

Joubrel C, Tazi A, Six A, Dmytruk N, Touak G, Bidet P, Raymond J, Trieu Cuot P, Fouet A, Kerneis S, Poyart C (2015) Group B streptococcus neonatal invasive infections, France 2007-2012. Clin Microbiol Infect 21(10):910–916. https://doi.org/10.1016/j.cmi.2015.05.039 CrossRefPubMed

Lagacé-Wiens PRS, Adam HJ, Low DE, Blondeau JM, Baxter MR, Denisuik AJ, Nichol KA, Walkty A, Karlowsky JA, Mulvey MR, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (2013) Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007–11. J Antimicrob Chemother 68(Suppl 1). https://doi.org/10.1093/jac/dkt023

10.

Lander F, Heinrich B, Hufnagel M, Flügge K, Kries RV, Berner R (2010) Epidemiologie invasiver Infektionen durch Escherichia coli bei Neugeborenen und jungen Säuglingen in Deutschland – Aktuelle Ergebnisse der laufenden ESPED-Studie. Klin Padiatr 222(S 01). doi:https://doi.org/10.1055/s-0030-1261467

11.

Le Doare K, O’Driscoll M, Turner K, Seedat F, Russell NJ, Seale AC, Heath PT, Lawn JE, Baker CJ, Bartlett L, Cutland C, Gravett MG, Ip M, Madhi SA, Rubens CE, Saha SK, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Kampmann B (2017) Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review. Clin Infect Dis 65(Suppl 2):S143–S151. https://doi.org/10.1093/cid/cix654 CrossRefPubMedPubMedCentral

12.

Lee J, Romero R, Kim SM, Chaemsaithong P, Yoon BH (2016) A new antibiotic regimen treats and prevents intra-amniotic inflammation/infection in patients with preterm PROM. J Matern Fetal Neonatal Med 29(17):2727–2737. https://doi.org/10.3109/14767058.2015.1103729 CrossRefPubMed

13.

Mayor-Lynn K, González-Quintero VH, O'Sullivan MJ, Hartstein AI, Roger S, Tamayo M (2005) Comparison of early-onset neonatal sepsis caused by Escherichia coli and group B Streptococcus. Am J Obstet Gynecol 192(5 SPEC. ISS):1437–1439. https://doi.org/10.1016/j.ajog.2004.12.031 CrossRefPubMed

14.

Mendoza-Palomar N, Balasch-Carulla M, González-Di Lauro S, Céspedes MC, Andreu A, Frick MA, Linde MÁ, Soler-Palacin P (2017) Escherichia coli early-onset sepsis: trends over two decades. Eur J Pediatr 176(9):1227–1234. https://doi.org/10.1007/s00431-017-2975-z CrossRefPubMed

15.

Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, Lynfield R, Vagnone PS, Burzlaff K, Spina NL, Dufort EM, Schaffner WS, Thomas AR, Farley MM, Jain JH, Pondo T, McGee L, Beall BW, Schrag SJ (2019) Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance. JAMA Pediatr 173:224–233. https://doi.org/10.1001/jamapediatrics.2018.4826 CrossRefPubMedPubMedCentral

16.

Schrag SJ, Farley MM, Petit S, Reingold A, Weston EJ, Pondo T, Jain JH, Lynfield R (2016) Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics 138(6):e20162013. https://doi.org/10.1542/peds.2016-2013 CrossRefPubMed

17.

Schulman J, Dimand RJ, Lee HC, Duenas GV, Bennett MV, Gould JB (2015) Neonatal intensive care unit antibiotic use. Pediatrics 135(5):826–833. https://doi.org/10.1542/peds.2014-3409 CrossRefPubMed

18.

Sharma D, Farahbakhsh N, Shastri S, Sharma P (2018) Biomarkers for diagnosis of neonatal sepsis: a literature review. J Matern Fetal Neonatal Med 31(12):1646–1659. https://doi.org/10.1080/14767058.2017.1322060 CrossRefPubMed

19.

Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile L-A, Poole WK (2002) Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 347(4):240–247. https://doi.org/10.1056/NEJMoa012657 CrossRefPubMed

20.

Tadesse DA, Zhao S, Tong E, Ayers S, Singh A, Bartholomew MJ, McDermott PF (2012) Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002. Emerg Infect Dis 18(5):741–749. https://doi.org/10.3201/eid1805.111153 CrossRefPubMedPubMedCentral

21.

The European Committee on Antimicrobial Susceptibility Testing (2019) Breakpoint tables for interpretation of MICs and zone diameters. Available at: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_9.0_Breakpoint_Tables.pdf.

22.

Tsai C-H, Chen Y-Y, Wang K-G, Chen C-Y, Chen C-P (2012) Characteristics of early-onset neonatal sepsis caused by Escherichia coli. Taiwan J Obstet Gynecol 51(1):26–30. https://doi.org/10.1016/j.tjog.2012.01.006 CrossRefPubMed

23.

Wicker E, Lander F, Weidemann F, Hufnagel M, Berner R, Krause G (2019) Group B streptococci: declining incidence in infants in Germany. Pediatr Infect Dis J 38(5):516–519. https://doi.org/10.1097/INF.0000000000002115 CrossRefPubMed

24.

Wolf MF, Miron D, Peleg D, Rechnitzer H, Portnov I, Salim R, Keness Y, Reich D, Ami MB, Peretz A, Koshnir A, Shachar IB (2015) Reconsidering the current preterm premature rupture of membranes antibiotic prophylactic protocol. Am J Perinatol 32(13):1247–1250. https://doi.org/10.1055/s-0035-1552935 CrossRefPubMed

25.

Yoon BH, Romero R, Park JY, Oh KJ, Lee J, Conde-Agudelo A, Hong J-S (2019) Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes. Am J Obstet Gynecol 221:142.e1–142.e22. https://doi.org/10.1016/j.ajog.2019.03.018 CrossRef

26.

Zea-Vera A, Ochoa TJ (2015) Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr 61(1):1–13. https://doi.org/10.1093/tropej/fmu079 CrossRefPubMedPubMedCentral

Title: Neonatal and young infant sepsis by Group B Streptococci and Escherichia coli: a single-center retrospective analysis in Germany—GBS screening implementation gaps and reduction in antibiotic resistance
Authors: Maren Doenhardt
Barbara Seipolt
Lars Mense
Jennifer Lucia Winkler
Alexander Thürmer
Mario Rüdiger
Reinhard Berner
Jakob Armann
Publication date: 01-11-2020
Publisher: Springer Berlin Heidelberg
Keywords: Escherichia Coli
Septicemia
Streptococci
Septicemia
Neonatal Sepsis
Antibiotic
Published in: European Journal of Pediatrics / Issue 11/2020
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-020-03659-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Neonatal and young infant sepsis by Group B Streptococci and Escherichia coli: a single-center retrospective analysis in Germany—GBS screening implementation gaps and reduction in antibiotic resistance

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2020

Renal follow-up in pediatrician practice after discharge from neonatology units: about a survey

Association of screen time with long-term stress and temperament in preschoolers: results from the DAGIS study

Early fluid overload is associated with mortality and prolonged mechanical ventilation in extremely low birth weight infants

Correction to: Time to positivity of Klebsiella pneumoniae in blood culture as prognostic indicator for pediatric bloodstream infections

Spot urine samples to estimate 24-hour urinary calcium excretion in school-age children

Time to positivity of Klebsiella pneumoniae in blood culture as prognostic indicator for pediatric bloodstream infections